| Target Price | zł596.70 |
| Price | zł442.00 |
| Potential |
35.00%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Creepy Jar 2027 .
The average Creepy Jar target price is zł596.70.
This is
35.00%
register free of charge
zł777.00
75.79%
register free of charge
zł434.30
1.74%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Creepy Jar to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Creepy Jar stock has an average upside potential 2027 of
35.00%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million zł | 29.83 | 63.43 |
| 3.71% | 112.63% | |
| EBITDA Margin | 56.12% | 69.98% |
| 15.21% | 24.70% | |
| Net Margin | 57.66% | 56.68% |
| 12.35% | 1.70% |
3 Analysts have issued a sales forecast Creepy Jar 2026 . The average Creepy Jar sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Creepy Jar EBITDA forecast 2026. The average Creepy Jar EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Creepy Jar Analysts have issued a net profit forecast 2026. The average Creepy Jar net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share zł | 23.64 | 51.36 |
| 8.14% | 117.26% | |
| P/E | 8.61 | |
| EV/Sales | 3.87 |
2 Analysts have issued a Creepy Jar forecast for earnings per share. The average Creepy Jar EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ERSTE GROUP |
Locked
➜
Locked
|
Locked | Jul 29 2026 |
| IPOPEMA SECURITIES |
Locked
➜
Locked
|
Locked | May 29 2026 |
| IPOPEMA SECURITIES |
Locked
➜
Locked
|
Locked | May 28 2026 |
| ERSTE GROUP |
Locked
➜
Locked
|
Locked | May 27 2026 |
| ERSTE GROUP |
Locked
➜
Locked
|
Locked | May 26 2026 |
| SANTANDER BROKERAGE POLAND |
Locked
➜
Locked
|
Locked | Apr 24 2026 |
| SANTANDER BROKERAGE POLAND |
Locked
➜
Locked
|
Locked | Apr 23 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
ERSTE GROUP:
Locked
➜
Locked
|
Jul 29 2026 |
|
Locked
IPOPEMA SECURITIES:
Locked
➜
Locked
|
May 29 2026 |
|
Locked
IPOPEMA SECURITIES:
Locked
➜
Locked
|
May 28 2026 |
|
Locked
ERSTE GROUP:
Locked
➜
Locked
|
May 27 2026 |
|
Locked
ERSTE GROUP:
Locked
➜
Locked
|
May 26 2026 |
|
Locked
SANTANDER BROKERAGE POLAND:
Locked
➜
Locked
|
Apr 24 2026 |
|
Locked
SANTANDER BROKERAGE POLAND:
Locked
➜
Locked
|
Apr 23 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


